http://www.woundmanagementtechnologies.com/ WNDM News en-us http://woundmanagementtechnologies.com/articles/wmt-2010-02-26-crx.php Wound Management Technologies, Inc. announced today that the recent increase in sales activities throughout the United States has resulted in 45 new clinicians evaluating their advanced wound care collagen product, CellerateRx®. In the last two months, these evaluations have transpired into new customers in Arizona, New Mexico, South Carolina, North Dakota, New Jersey, Wyoming, Colorado, and New York. Fri, 26 Feb 2010 15:45:00 GMT http://woundmanagementtechnologies.com/articles/wmt-2010-02-23-roger-vp.php Wound Management Technologies, Inc. announced today that its secure data delivery and messaging subsidiary Secure eHealth, LLC has appointed Roger Fallows as Vice President of Sales. In this role Roger will lead the sales department by continuing to pursue the numerous opportunities and partnerships that have evolved since the acquisition of Secure eHealth by Wound Management earlier this month. "Roger is a dynamic and highly experienced sales professional with deep roots in the healthcare space," said Robert Tapales, President of Secure eHealth. "We are all very pleased to have him on board to help execute the aggressive sales strategy planned for the company this year," Tapales continues. Tue, 23 Feb 2010 14:30:00 GMT http://www.woundmanagementtechnologies.com/articles/wmt-2010-02-04-gsi-health.php Wound Management Technologies, Inc. announced today that its subsidiary Secure eHealth LLC has completed a consulting agreement with GSI Health. GSI Health is led by Leroy E. Jones, who is a principal and Chief Executive Officer. Under the Consulting Agreement , GSI Health will focus primarily on the market penetration and development of Secure eHealth's suite of secure messaging, authentication and notification products. "We are looking forward to benefiting a great deal from Lee's expertise in the market to help boost our penetration into the healthcare space with these products. Having someone with his experience guiding us will assist us in getting to the top of the list of security solutions in an industry where it is so desperately needed," says Deborah Jenkins-Hutchinson, Wound Management Technologies president. Thu, 04 Feb 2010 14:30:00 GMT http://www.woundmanagementtechnologies.com/articles/wmt-2010-02-01-seh-to-wmt.php Wound Management Technologies, Inc. announced today that it has completed the acquisition of secure data and messaging provider, Secure eHealth, LLC, along with certain other technology assets from VirtualHealth Technologies, Inc. (OTC Bulletin Board: VHGI) as previously announced in the January 11 press release. In addition to the acquisition of Secure eHealth, Wound Management has also received all of the intellectual property assets of the real-time prescription drug monitoring business conducted by VHGI subsidiary, VPS Holdings. In addition, VHGI transferred to Wound Management its interest in a convertible note issued by Private Access, Inc., along with related agreements . Private Access is the Irvine based innovator in privacy-enhanced search technology and licensee of Secure eHealth's System Tray Notifier. VHGI will retain its existing ownership interest in Private Access. Terms of the sale include $100,000 in cash, a note for $400,000, and a three-year 10% royalty payable by WNDM and its subsidiaries to VHGI for sales of products containing the Veriscrip Technology. Mon, 01 Feb 2010 14:30:00 GMT http://www.woundmanagementtechnologies.com/articles/wmt-2010-01-25-present.php Wound Management Technologies, Inc. announced today that its subsidiary, Wound Care Innovations, LLC, has renewed its agreement as a major sponsor for PRESENT Podiatry and as an educational sponsor for PRESENT Diabetes. PRESENT e-Learning Systems is dedicated to improving the knowledge and skills of medical professionals throughout the world by providing high quality medical education programming via the Internet and by fostering collaboration with their peers at worldwide centers of excellence. PRESENT Podiatry now publishes to over 9,000 podiatrists and 800 podiatric students with lecture views of over 62,000. PRESENT Diabetes now publishes to 82,394 diabetes healthcare professionals and in the month of December 2009, received 28,785 unique visitors. Mon, 25 Jan 2010 22:00:00 GMT http://www.woundmanagementtechnologies.com/articles/wmt-2010-01-19-hira.php Wound Management Technologies, Inc., a rapidly growing provider of specialty medical products, announced today that its subsidiary Wound Care Innovations was highlighted as part of a presentation exhibited at the SuperBones East conference in Nassau, Bahamas, on January 14-17. The SuperBones Conference has a great reputation for high quality educational lectures and workshops and places top national speakers at the podium. It was designed to provide a specialty education format that includes vital industry topics and techniques to medical practitioners that specialize in treatment of the lower extremities. Tue, 19 Jan 2010 16:00:00 GMT http://woundmanagementtechnologies.com/articles/wmt-2010-01-18-tabak.php Wound Management Technologies, Inc., a rapidly growing provider of specialty medical products, announced today that it has engaged National Investment Banking firm Miller Tabak & Co., LLC, a twenty-eight year old institutional trading firm as part of it strategy in accelerating the search for potential partners that will help grow revenues which are necessary to execute Wound Managements plans for 2010. According to Deborah Jenkins Hutchinson, Wound Management President " We believe that partnering with Miller Tabak will be a key relationship to help us identify the partners that will benefit WMT the most and will help us to reach our strategic goals this year more quickly." The agreement is performance based. Mon, 18 Jan 2010 22:00:00 GMT http://woundmanagementtechnologies.com/articles/wmt-2010-01-13-expands-presence.php Wound Management Technologies, Inc. announced today that it is nearing the completion of its registration of CellerateRX in Mexico and has identified its first distributor in that country. Numerous physicians in the nation have already evaluated the Activated Collagen wound care product and were impressed with its speed and efficacy in the management of diabetic ulcers and are optimistic that it will play a tremendous role in the management of these types of wounds. Wed, 13 Jan 2010 00:35:00 GMT http://woundmanagementtechnologies.com/articles/wmt-2010-01-12-president.php Wound Management Technologies, Inc., has named Deborah Jenkins Hutchison as its new president to help spearhead WNDM's leveraging of its existing technology and infrastructure to develop opportunities in the rapidly growing markets of biotech and genetic engineering, and to expand WNDM's technology footprint. WNDM noted that the appointment is extremely timely in light of their upcoming acquisition of Secure eHealth, a technology provider for Wound Care Innovations and for Private Access, an Irvine based innovator in privacy-enhanced search technology who is collaborating with Pfizer and the Genetic Alliance to develop an online community to accelerate clinical research. Tue, 12 Jan 2010 22:10:00 GMT http://woundmanagementtechnologies.com/articles/wmt-2010-01-11-seh-sale.php Wound Management Technologies, Inc. announced today that they have reached a mutual understanding and verbal agreement in principle to acquire secure data and messaging provider, Secure eHealth, LLC, and certain other technology assets from VirtualHealth Technologies, Inc. (OTCBB: VHGI). The parties have completed the due diligence process, agreed to the price and terms and are currently drafting and negotiating definitive documentation on this transaction and expect to close the transaction within the next two weeks. In addition to acquiring Secure eHealth, Wound Management will also be acquiring from VHGI all of the intellectual property assets of the real-time prescription drug monitoring company Veriscrip and the Private Access Convertible Note and Agreements. Wound Care Innovations, a WNDM subsidiary, currently licenses the Cifra solution from Secure eHealth and will initially use this highly secure messaging system, document courier and database to share and compile information for ongoing evidence based case studies on its patented collagen CellerateRx® products for treating diabetic wounds. Mon, 11 Jan 2010 15:15:00 GMT http://www.woundmanagementtechnologies.com/articles/wmt-2009-12-16-bio-materials.php Wound Management Technologies, Inc. (WNDM) a rapidly growing provider of specialty medical products, announced today that its Resorbable Orthopedics operating subsidiary is moving toward productization of its patented orthopedic bone void fillers. The company currently anticipates products to be introduced in Q3 2010, to the bio-products market, estimated to be a multi-billion dollar international market. Wed, 16 Dec 2009 20:14:00 GMT http://www.woundmanagementtechnologies.com/articles/wmt-2009-12-03-hira-agreement.php Wound Management Technologies, Inc. (OTCBB-WNDM), a rapidly growing provider of specialty medical products, announced today an agreement with the Health Industry Representative Association (HIRA) to serve as a non-exclusive independent sales and marketing representative to market the company's core CellerateRx® product within the U.S. Thu, 3 Dec 2009 16:30:00 GMT http://www.woundmanagementtechnologies.com/articles/wmt-2009-12-01-va-conference.php Wound Management Technologies, Inc., a rapidly growing provider of specialty medical products, announced today that further positive case study data on CellerateRX&, the core product of the Wound Care Innovations, LLC operating subsidiary, was released at the recent 6th Annual High Risk Diabetic Foot Conference for VA Podiatrists and Healthcare Professional in Tempe, AZ. Tue, 1 Dec 2009 14:30:00 GMT http://www.woundmanagementtechnologies.com/articles/wmt-2009-11-23-revenue-update.php Wound Management Technologies, Inc., (WNDM), announced today that its BioPharma Management Technologies Division will search for partners to aid in leveraging its existing technology and infrastructure to develop opportunities within the International Biotechnology and Genetic Engineering fields. The company intends to announce developments concerning advisory board appointments, research affiliations, and new partners as details emerge. Mon, 23 Nov 2009 15:53:00 GMT http://www.woundmanagementtechnologies.com/articles/wmt-2009-11-05-wmt-buys-vhgi.php Wound Management Technologies, Inc., (WNDM), announced today that it has entered into a Letter of Intent to purchase all healthcare-related assets of Virtual Health Technologies, Inc. (OTCBB-VHGI). The deal provides for VHGI to be paid $1,000,000 in cash and debt, 4,000,000 shares of WNDM and a royalty agreement for revenues generated by WNDM on the Veriscrip technology being acquired from VHGI. WNDM closed at $2.00 per share on 11/4/09 and VHGI closed at $0.27 per share on 11/4/09. Thu, 05 Nov 2009 14:30:00 GMT http://www.woundmanagementtechnologies.com/articles/wmt-2009-11-03-cytokine-presentation.php WNDM announced today that a clinical study, "Activated Collagen Accelerates Wound Repair and Modulates Cytokine Production in Whole Blood and PBMC Cultures" was presented at the Tri-Society Annual Conference 2009 of the Society for Leukocyte Biology, International Cytokine Society, & International Society for Interferon and Cytokine Research, Cellular and Cytokine Interactions in Health and Disease in Lisbon, Portugal, October 18-21, 2009. Tue, 03 Nov 2009 14:45:00 GMT http://www.woundmanagementtechnologies.com/articles/wmt-2009-10-26-BiocureAgreement.php WNDM through its subsidiary, Wound Care Innovations, announced today that it has reached an agreement with Biocure S.r.l. of Milan, Italy for the distribution of WNDM's patented molecular form of activated collagen, CellerateRx®. Mon, 26 Oct 2009 13:30:00 GMT http://www.woundmanagementtechnologies.com/articles/wmt-2009-10-16-crx-study.php WNDM a rapidly growing provider of specialty medical products, announced today that its subsidiary Wound Care Innovations, LLC will exhibit at the 24th Annual Clinical Symposium on Advances in Skin & Wound Care: The Conference for Prevention and Healing, which opens on October 22 in San Antonio. Mon, 16 Oct 2009 13:30:00 GMT http://www.woundmanagementtechnologies.com/articles/wmt-2009-10-12-wmt-launches-cifra.php WNDM, a rapidly growing provider of specialty medical products, announced today that its subsidiary Wound Care Innovations, LLC has launched the Cifra healthcare platform to securely exchange and store information for ongoing evidence based case studies on its patented collagen CellerateRx® products in managing all types of wound care. Mon, 12 Oct 2009 13:30:00 GMT http://www.woundmanagementtechnologies.com/articles/wmt-2009-10-07-save-a-leg.php WNDM, a rapidly growing provider of specialty medical products, announced today that the company will actively participate at the Save A Leg, Save a Life Foundation National Conference (SALSAL) that opens in Orlando tomorrow, October 8. Tue, 6 Oct 2009 13:30:00 GMT http://www.woundmanagementtechnologies.com/articles/wmt-2009-10-01-acquires-resorbable-orthopedics.php WNDM, a rapidly growing provider of specialty medical products, announced today it has closed on its acquisition of Resorbable Orthopedics LLC, a private company with patented technologies including a resorbable bone wax and a delivery system for orthopedic bone void fillers, among others. Thu, 1 Oct 2009 13:22:00 GMT http://www.woundmanagementtechnologies.com/articles/wmt-2009-09-28-adds-sales-organization.php WNDM announced today an agreement with Med Pro Associates of Colorado, to serve as a non-exclusive independent sales and marketing representative to solicit sales, obtain orders and provide sales and marketing support for the company's line of products within the U.S. Tue, 29 Sep 2009 13:56:01 GMT http://www.woundmanagementtechnologies.com/articles/wmt-2009-09-24-middle-east-marketing-initiative.php WNDM announced today an agreement with Pharma Technology International, LLC (Pharma Tech) to market, distribute and sell the company's wound care products in the Middle East. Pharma Tech is a joint venture between A&Z Pharmaceutical and BioPharma Management Technologies, Inc., a company recently acquired by Wound Management Technologies. Thu, 24 Sep 2009 15:22:00 GMT http://www.woundmanagementtechnologies.com/articles/wmt-2009-09-21-diabetic-conference.php WNDM announced today its subsidiary Wound Care Innovations, LLC, will exhibit at the Georgetown University Hospital's Team Approach to Diabetic Limb Salvage (DLS) conference in Washington, D.C. September 24th-26th. Mon, 21 Sep 2009 14:00:00 GMT http://www.woundmanagementtechnologies.com/articles/wmt-2009-09-17-strategic-acquisition.php WNDM announced today that it has completed the acquisition of BioPharma Management Technologies, Inc., a privately held biotechnology company with a platform of proprietary and patented technologies for topical pain management and resorbable orthoses. Thu, 17 Sep 2009 20:58:00 GMT